Polymorphisms in FcγRIIIA (CD16) Receptor Expression Are Associated With Clinical Response to Rituximab in Waldenström’s Macroglobulinemia
Journal of Clinical Oncology - United States
doi 10.1200/jco.2005.06.059
Full Text
Open PDFAbstract
Available in full text
Date
January 20, 2005
Authors
Publisher
American Society of Clinical Oncology (ASCO)